Mark Andrew Wilson, SVP & General Counsel at NEKTAR THERAPEUTICS (NKTR), sold 1,529 shares at $22.51 ($34K) on 2020-05-18, disclosed to the SEC on 2020-05-20.
Open-market sale of $34k NKTR by SVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |